Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - Euronext Paris - Matif - FR0010313833 - Common Stock - Currency: EUR

74.55  -1.25 (-1.65%)

Fundamental Rating

5

Taking everything into account, AKE scores 5 out of 10 in our fundamental rating. AKE was compared to 60 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE is valued quite cheap, while showing a decent growth score. This is a good combination! Finally AKE also has an excellent dividend rating. This makes AKE very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
In the past 5 years AKE has always been profitable.
In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE has a better Return On Assets (2.22%) than 65.00% of its industry peers.
The Return On Equity of AKE (4.49%) is better than 63.33% of its industry peers.
With a decent Return On Invested Capital value of 3.98%, AKE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AKE is in line with the industry average of 6.56%.
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROIC 3.98%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of AKE (3.54%) is better than 65.00% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
AKE's Operating Margin of 7.52% is fine compared to the rest of the industry. AKE outperforms 70.00% of its industry peers.
In the last couple of years the Operating Margin of AKE has declined.
AKE has a Gross Margin of 20.32%. This is in the lower half of the industry: AKE underperforms 61.67% of its industry peers.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
Compared to 5 years ago, AKE has less shares outstanding
The debt/assets ratio for AKE is higher compared to a year ago.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.86 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AKE (1.86) is comparable to the rest of the industry.
The Debt to FCF ratio of AKE is 12.65, which is on the high side as it means it would take AKE, 12.65 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AKE (12.65) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.49 indicates that AKE is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.49, AKE perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Altman-Z 1.86
ROIC/WACC0.78
WACC5.13%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.01. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE has a Current ratio of 2.01. This is in the better half of the industry: AKE outperforms 66.67% of its industry peers.
AKE has a Quick Ratio of 1.47. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a better Quick ratio (1.47) than 68.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.47
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

AKE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.06%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
The Revenue has been growing slightly by 0.32% in the past year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-6.06%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-10.56%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%2.07%

3.2 Future

AKE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 2.86% on average per year.
EPS Next Y16.22%
EPS Next 2Y14.13%
EPS Next 3Y15.42%
EPS Next 5Y8.49%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y2.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.08, the valuation of AKE can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 93.33% of the companies listed in the same industry.
AKE is valuated cheaply when we compare the Price/Earnings ratio to 29.07, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.81, the valuation of AKE can be described as very cheap.
Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 98.33% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.05. AKE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.08
Fwd PE 7.81
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaply inside the industry as 88.33% of the companies are valued more expensively.
73.33% of the companies in the same industry are more expensive than AKE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.75
EV/EBITDA 5.44
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

AKE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AKE's earnings are expected to grow with 15.42% in the coming years.
PEG (NY)0.56
PEG (5Y)92.91
EPS Next 2Y14.13%
EPS Next 3Y15.42%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.49%, AKE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.99, AKE pays a better dividend. On top of this AKE pays more dividend than 88.33% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 4.49%

5.2 History

On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years3
Div Non Decr Years3
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AKE pays out 77.22% of its income as dividend. This is not a sustainable payout ratio.
AKE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP77.22%
EPS Next 2Y14.13%
EPS Next 3Y15.42%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (3/26/2025, 5:36:15 PM)

74.55

-1.25 (-1.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners52.1%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap5.67B
Analysts81.82
Price Target106.53 (42.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.49%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP77.22%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.09%
Min EPS beat(2)-18.44%
Max EPS beat(2)-1.73%
EPS beat(4)2
Avg EPS beat(4)-0.7%
Min EPS beat(4)-18.44%
Max EPS beat(4)8.93%
EPS beat(8)5
Avg EPS beat(8)1.72%
EPS beat(12)9
Avg EPS beat(12)9.54%
EPS beat(16)13
Avg EPS beat(16)15.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-0.57%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)2
Avg Revenue beat(8)-1.34%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)-1.07%
PT rev (3m)-2.85%
EPS NQ rev (1m)-15.7%
EPS NQ rev (3m)-19.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.73%
Revenue NQ rev (1m)-1.47%
Revenue NQ rev (3m)-3.06%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE 9.08
Fwd PE 7.81
P/S 0.59
P/FCF 15.75
P/OCF 5.06
P/B 0.75
P/tB 2.72
EV/EBITDA 5.44
EPS(TTM)8.21
EY11.01%
EPS(NY)9.54
Fwd EY12.8%
FCF(TTM)4.73
FCFY6.35%
OCF(TTM)14.74
OCFY19.77%
SpS125.48
BVpS98.95
TBVpS27.37
PEG (NY)0.56
PEG (5Y)92.91
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROCE 5.64%
ROIC 3.98%
ROICexc 4.74%
ROICexgc 9.65%
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
FCFM 3.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Debt/EBITDA 2.42
Cap/Depr 94.89%
Cap/Sales 7.97%
Interest Coverage 44.88
Cash Conversion 73.75%
Profit Quality 106.51%
Current Ratio 2.01
Quick Ratio 1.47
Altman-Z 1.86
F-Score4
WACC5.13%
ROIC/WACC0.78
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.06%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-10.56%
EPS Next Y16.22%
EPS Next 2Y14.13%
EPS Next 3Y15.42%
EPS Next 5Y8.49%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%2.07%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y2.86%
EBIT growth 1Y-11.47%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year88.55%
EBIT Next 3Y30.59%
EBIT Next 5Y17.08%
FCF growth 1Y-39.39%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-11.87%
OCF growth 3Y7%
OCF growth 5Y-2.92%